
Unveiling the Growing Impact of Chronic Kidney Disease on Patients, the Environment, and Economies
A recent modeling analysis conducted by AstraZeneca, named IMPACT CKD, projects that by 2032, up to 16.5% of the population across eight countries will be afflicted by chronic kidney disease (CKD), with an expected increase of up to 59.3% in…